VALIDATED EXECUTIVE ENGAGEMENTS
OUTREACH
11338
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1361
Interactions with Platform & by Email
PARTICIPANTS
342
Unique # Participated
VALIDATIONS
154
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
306
PAGES
533
EDITION
19
PRICE
USD $5450
Is the U.S. Still a Better Global Barometer than China?
Amid the COVID-19 crisis, the global market for Antibiotics estimated at US$42.7 Billion in the year 2020, is projected to reach a revised size of US$45.7 Billion by 2027, growing at a CAGR of 1% over the analysis period 2020-2027. Beta Lactam & Beta Lactamase Inhibitors, one of the segments analyzed in the report, is projected to record a 1.4% CAGR and reach US$19.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Quinolone segment is readjusted to a revised 0.4% CAGR for the next 7-year period.
The Antibiotics market in the U.S. is estimated at US$11.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.5 Billion by the year 2027 trailing a CAGR of 2.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.2% and 0.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.1% CAGR.
In the global Macrolide segment, USA, Canada, Japan, China and Europe will drive the 0.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$8.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.9 Billion by the year 2027, while Latin America will expand at a 1.3% CAGR through the analysis period. We bring years of research experience to this 19th edition of our report. The 533-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories, Inc.; Allergan PLC; Aurobindo Pharma Ltd.; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Lupin Pharmaceuticals, Inc.; Merck & Co., Inc.; Mylan NV; Novartis International AG; Pfizer, Inc.; Sanofi; Shionogi, Inc.; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.
» Drug Class (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, and Other Drug Classes) » Drug Origin (Natural, Semisynthetic, and Synthetic) » Route of Administration (Oral, Intravenous, and Other Route of Administrations)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Antibiotics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Antibiotics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Antibiotics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Antibiotics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Beta Lactam & Beta Lactamase Inhibitors (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Beta Lactam & Beta Lactamase Inhibitors (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Beta Lactam & Beta Lactamase Inhibitors (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Quinolone (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Quinolone (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Quinolone (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Macrolide (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Macrolide (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Macrolide (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Classes (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Other Classes (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Other Classes (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Natural (Drug Origin) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Natural (Drug Origin) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Natural (Drug Origin) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Semisynthetic (Drug Origin) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
| Semisynthetic (Drug Origin) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Semisynthetic (Drug Origin) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Synthetic (Drug Origin) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 |
| Synthetic (Drug Origin) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 |
| Synthetic (Drug Origin) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Oral (Route of Administration) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Oral (Route of Administration) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Oral (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Intravenous (Route of Administration) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Intravenous (Route of Administration) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Intravenous (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Antibiotics Market Share (in %) by Company: 2019 & 2025 |
| United States Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025 |
| Antibiotics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017 |
| United States Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| United States Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025 |
| Antibiotics Market in the United States by Drug Origin: A Historic Review in US$ Million for 2009-2017 |
| United States Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| United States Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 |
| Antibiotics Market in the United States by Route of Administration: A Historic Review in US$ Million for 2009-2017 |
| United States Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| Canadian Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017 |
| Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025 |
| Canadian Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017 |
| Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025 |
| Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| Canadian Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017 |
| Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| Japan |
| Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| Japanese Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017 |
| Japanese Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| Japanese Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| China |
| Chinese Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017 |
| Chinese Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in China in US$ Million by Drug Origin: 2009-2017 |
| Chinese Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in China in US$ Million by Route of Administration: 2009-2017 |
| Chinese Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Europe |
| Market Facts & Figures |
| European Antibiotics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Antibiotics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Antibiotics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Antibiotics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Antibiotics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| European Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| European Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025 |
| Antibiotics Market in Europe in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017 |
| European Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| European Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Antibiotics Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| European Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| France |
| Antibiotics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017 |
| French Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in France by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017 |
| French Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 |
| French Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Germany |
| Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| German Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| German Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| German Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| German Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| German Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| German Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017 |
| Italian Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Italy in US$ Million by Drug Origin: 2009-2017 |
| Italian Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Italy in US$ Million by Route of Administration: 2009-2017 |
| Italian Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| United Kingdom |
| United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| United Kingdom Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017 |
| United Kingdom Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| United Kingdom Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Spain |
| Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| Spanish Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017 |
| Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025 |
| Spanish Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017 |
| Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025 |
| Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| Spanish Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017 |
| Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| Russia |
| Russian Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025 |
| Antibiotics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017 |
| Russian Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Russian Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025 |
| Antibiotics Market in Russia by Drug Origin: A Historic Review in US$ Million for 2009-2017 |
| Russian Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Russian Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 |
| Antibiotics Market in Russia by Route of Administration: A Historic Review in US$ Million for 2009-2017 |
| Russian Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Antibiotics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| Rest of Europe Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025 |
| Antibiotics Market in Rest of Europe in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017 |
| Rest of Europe Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Antibiotics Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| Rest of Europe Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Asia-Pacific Antibiotics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Antibiotics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Antibiotics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017 |
| Asia-Pacific Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Asia-Pacific by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017 |
| Asia-Pacific Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 |
| Asia-Pacific Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Australia |
| Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| Australian Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| Australian Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| Australian Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| Australian Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| Australian Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| Australian Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| India |
| Indian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| Indian Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017 |
| Antibiotics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| Indian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025 |
| Indian Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017 |
| Antibiotics Market in India: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025 |
| Indian Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| Indian Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017 |
| Antibiotics Market in India: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| South Korea |
| Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| South Korean Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| Antibiotics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| South Korean Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| Antibiotics Market Share Distribution in South Korea by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| South Korean Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| Antibiotics Market Share Distribution in South Korea by Route of Administration: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| Rest of Asia-Pacific Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017 |
| Rest of Asia-Pacific Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| Rest of Asia-Pacific Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Antibiotics Market Trends by Region/Country in US$ Million: 2018-2025 |
| Antibiotics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Antibiotics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017 |
| Latin American Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Latin America in US$ Million by Drug Origin: 2009-2017 |
| Latin American Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Latin America in US$ Million by Route of Administration: 2009-2017 |
| Latin American Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Argentina |
| Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Antibiotics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| Argentinean Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025 |
| Antibiotics Market in Argentina in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017 |
| Argentinean Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Antibiotics Market in Argentina in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| Argentinean Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Brazil |
| Antibiotics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017 |
| Brazilian Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Brazil by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017 |
| Brazilian Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Brazil by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 |
| Brazilian Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Mexico |
| Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| Mexican Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| Mexican Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| Mexican Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| Mexican Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| Mexican Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| Mexican Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025 |
| Antibiotics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025 |
| Antibiotics Market in Rest of Latin America by Drug Origin: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 |
| Antibiotics Market in Rest of Latin America by Route of Administration: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Antibiotics Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Antibiotics Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| The Middle East Antibiotics Historic Market by Drug Class in US$ Million: 2009-2017 |
| Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025 |
| The Middle East Antibiotics Historic Market by Drug Origin in US$ Million: 2009-2017 |
| Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025 |
| The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| The Middle East Antibiotics Historic Market by Route of Administration in US$ Million: 2009-2017 |
| Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| Iran |
| Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| Iranian Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017 |
| Iranian Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025 |
| Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| Iranian Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Antibiotics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| Israeli Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025 |
| Antibiotics Market in Israel in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017 |
| Israeli Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Antibiotics Market in Israel in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| Israeli Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Saudi Arabia |
| Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017 |
| Saudi Arabian Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Origin: 2009-2017 |
| Saudi Arabian Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Route of Administration: 2009-2017 |
| Saudi Arabian Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| United Arab Emirates |
| Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| Antibiotics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| Antibiotics Market Share Distribution in United Arab Emirates by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| Antibiotics Market Share Distribution in United Arab Emirates by Route of Administration: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| Rest of Middle East Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025 |
| Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017 |
| Rest of Middle East Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| Rest of Middle East Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| Africa |
| African Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025 |
| Antibiotics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017 |
| African Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| African Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025 |
| Antibiotics Market in Africa by Drug Origin: A Historic Review in US$ Million for 2009-2017 |
| African Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025 |
| African Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 |
| Antibiotics Market in Africa by Route of Administration: A Historic Review in US$ Million for 2009-2017 |
| African Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 197 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com